Jun
2026
Shanghai New International Expo Center
Visit us
stand E3P06, Finished Dosage

CISEN PHARMACEUTICAL CO., LTD.

About Us

Cisen Pharma is an integrated chemical pharmaceutical Co.,Ltd., which was founded on 1970 and listed on main board of SGX 2017. Our products cover the seven following dosage form: LVP\SVP\OSD\Lyophilized PFI(Including PFI)\External Use Product\API\ FSMP(Food for Special Medical Purpose). The following eight therapuetic area: Parenteral Nutrition, Antineoplastic, CVD, Digestive system, Diabetes, Respiratory System, Anesthesia and its aid, Anti-depression are included. External use product, such as eye drop, ointment, cream, aseptic eye ointment;API: Heparin Sodium;Enoxaparin Sodium;Dexmedetomidine HCL and so on.

  • Country/Region:
    China
  • On CPHI since:
    2015
Company types
Manufacturer/Innovator
Contact info
Event information
CPHI & PMEC China 2026
  • 16 Jun 2026 - 18 Jun 2026
  • Shanghai New International Expo Center
  • Visit us at stand E3P06, Finished Dosage

Products Featured at CPHI & PMEC China 2026

  • Carbetocin injection

    Product Carbetocin injection

    ² It is used as the first-line medication to prevent postpartum hemorrhage caused by vaginal delivery and cesarean section.

    ² Traditional oxytocin products have been upgraded to have stronger metabolic stability, higher bioavailability, longer acting effect, stronger potency, and are s...
  • Esomeprazole Magnesium Delayed Release Capsule

    Product Esomeprazole Magnesium Delayed Release Capsule

    Treatment of Gastroesophageal Reflux Disease (GERD)

    Risk Reduction of NSAID-Associated Gastric Ulcer

    H. pylori Eradication to Reduce the Risk of Duodenal Ulcer Recurrence

    Pathological Hypersecretory Conditions Including Zoll...
  • Metoprolol succinate sustained release capsules

    Product Metoprolol succinate sustained release capsules

    1. Hypertension

    Metoprolol succinate sustained release capsules are indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure lowers the risk of fatal and non-fatal cardiovascular events, primarily strokes and myocardial infarctions.

    2. Angina...
  • Sitagliptin and Metformin Tablets (Ⅱ)

    Product Sitagliptin and Metformin Tablets (Ⅱ)

    ² The combination therapy of sitagliptin and metformin can significantly improve glycemic control in patients with type 2 diabetes mellitus.

    ² Combination therapy provides significant and long-lasting glycemic control and improves β-cell function indicators in patients with type 2 diab...